首页> 外国专利> Composition for treating liver fibrosis and treatment method for liver fibrosis

Composition for treating liver fibrosis and treatment method for liver fibrosis

机译:用于治疗肝纤维化和肝纤维化处理方法的组合物

摘要

PROBLEM TO BE SOLVED: To inhibit the expression of a double-stranded ribonucleic acid (dsRNA) composition targeting a COL1A1 gene, a TGF-β gene, or a SMAD2 / 3 gene, and COL1A1, TGF-β, or SMAD2 / 3. Provided is a method of using the dsRNA composition for the purpose. A dsRNA for inhibiting the expression of COL1A1, TFGβ, or SMAD2 / 3, wherein the dsRNA contains a sense strand and an antisense strand, and the sense strand is 3 or less with a specific nucleotide sequence. The antisense strand comprises at least 15 contiguous nucleotides with different nucleotides and the antisense strand comprises at least 15 contiguous nucleotides with 3 or less nucleotides different from the antisense nucleotide sequence corresponding to a particular sequence. dsRNA. [Selection diagram] FIG. 13
机译:要解决的问题:抑制靶向COL1A1基因,TGF-β基因或SMAD2 / 3基因的双链核糖核酸(DSRNA)组合物,以及COL1A1,TGF-β或SMAD2 / 3的表达。 提供了一种使用DSRNA组合物的方法。 用于抑制COL1A1,TFGβ或SMAD2 / 3的表达的DSRNA,其中DSRNA含有义链和反义链,并且具有特定核苷酸序列的感测链为3或更小。 反义链包含至少15个具有不同核苷酸的连续核苷酸,并且反义链包含至少15个与与特定序列对应的反义核苷酸序列不同的3或更少核苷酸的连续核苷酸。 dsrna。 [选择图]图。 13.

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号